MEITAV INVESTMENT HOUSE LTD - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 33 filers reported holding REDHILL BIOPHARMA LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q1 2020$57,000
-46.7%
13,000
-10.3%
0.00%
-50.0%
Q3 2019$107,000
+13.8%
14,5000.0%0.01%
+33.3%
Q2 2019$94,000
-23.6%
14,5000.0%0.01%
-14.3%
Q1 2019$123,000
-55.8%
14,500
-71.0%
0.01%
-58.8%
Q4 2018$278,000
-34.1%
50,000
+2.7%
0.02%
-19.0%
Q3 2018$422,000
+8.8%
48,706
+1.5%
0.02%
+23.5%
Q2 2018$388,000
+57.1%
48,0000.0%0.02%
+30.8%
Q1 2018$247,000
+1.2%
48,0000.0%0.01%
-7.1%
Q4 2017$244,00048,0000.01%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q4 2017
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders